450 [5] [6] [7] [8] [9] D.-Y. Lu et al.: Herman EH, Witiak DT, Hellmann K, Waradek VS. Properties of ICRF-159 and related Bis(dioxopiperazine) compounds. Adv Pharmacol Chemother. 1982; 19: 249–290. doi:10.1016/S1054-3589(08)60025-3 Ji RY. Probimane. Drugs Fut. 1988; 13: 418–419 Lu DY, Xu B, Ding J. Antitumor effects of two bisdioxopiperazines against two experimental lung cancer models in vivo. BMC Pharmacol. 2004; 4: 32. doi:10.1186/1471-2210-4-32 Lu DY, Huang M, Xu CH, Yang WY, Hu CX, Lin LP, Tong LJ, Li MH, Lu W, Zhang XW, Ding J. Anti-proliferative effects, cell cycle G2/M phase arrest and blocking of chromosome segregation by probimane and MST-16 in human tumor cell lines. BMC Pharmacol. 2005; 5: 11. doi:10.1186/1471-2210-5-11 Lu DY, Huang M, Xu CH, Zhu H, Xu B, Ding J. Medicinal Chemistry of probimane and MST-16: comparison of anticancer effects between bisdioxopiperazines. Med Chem. 2006; 2: 369–375. doi:10.2174/157340606777724095 [10] Salsbury AJ, Burrage K, Hellmann K. Histological analysis of the antimetastatic effect of (±)-1,2-bis(3,5-dioxopiperazin-1-yl) propane. Cancer Res. 1974; 34: 843–849. PMid:4814997 [11] Braybrooke JP, O’Byrne KJ, Propper DJ, Blann A, Saunders M, Dobbs N, Han C, Woodhull J, Mitchell K, Crew J, Smith K, Stephens R, Ganesan TS, Talbot DC, Harris AL. A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis. Clin Cancer Res. 2000; 6: 4697–4704. PMid:11156222 [12] Hellmann K. Dynamics of tumor angiogenesis: effect of razoxane- induced growth rate slowdown. Clin Exp Metastasis. 2003; 20: 95–102. doi:10.1023/A:1022632413888 [13] Lu DY, Chi J, Lin LP, Huang M, Xu B, Ding J. Effect of anticancer drugs on the binding of 125I-fibrinogen to two leukaemia cell lines in vitro. J Int Med Res. 2004; 32: 488–491. PMid:15458280 [14] Lu DY, Liang G, Zhang MJ, Xu B. Serum contents of sialic acids in mice bearing different tumors. Chin Sci Bull. 1994; 39: 1220–1223. [15] Lu DY, Wu FG, Shen ZM, Lu TR, Wu HY, Che JY, Xu B. Different spontaneous pulmonary metastasis inhibitions against Lewis lung carcinoma in mice by Bisdiopiperazine compounds of different treatment schedules. Sci Pharm, 2010; 78: 13–20. doi:10.3797/scipharm.0910-16 [16] Greig N, Fang XC, Hellmann K. Razoxane penetration into the cerebrospinal fluid of rats. Cancer Chemother Pharmacol. 1982; 8: 251–252. PMid:7105386 Sci Pharm. 2010; 78: 445–450.